CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Taro Pharmaceutical Industries Ltd Company Snapshot
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.

Sales Analysis. During the year ended March of 2017, sales at Taro Pharmaceutical Industries Ltd were 3.32 billion Israel Shekels (US$942.81 million). This is a decrease of 9.6% versus 2016, when the company's sales were 3.67 billion Israel Shekels.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Taro Pharmaceutical Industries Ltd
  Stock Performance Chart for Taro Pharmaceutical Industries Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): 411.08
(Figures in Israel Shekels)
1 Week 4.8%   13 Weeks 10.5%  
4 Weeks -3.3%   52 Weeks -23.8%  
 
Taro Pharmaceutical Industries Ltd Key Data:
  Ticker: TARO Country: Israel
  Exchanges: NAS TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 3,320,574,106
(Year Ending Jan 2018).
Employees: 1,413
  Currency: Israel Shekels Market Cap: 16,655,421,895
  Fiscal Yr Ends: March Shares Outstanding: 40,515,809
  Share Type: Ordinary Closely Held Shares: 29,500,413
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.